172 related articles for article (PubMed ID: 23398333)
21. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.
Zeydan B; Lowe VJ; Reichard RR; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Parisi JE; Machulda MM; Vemuri P; Mielke MM; Knopman DS; Petersen RC; Jack CR; Kantarci OH; Kantarci K
Ann Neurol; 2020 Apr; 87(4):556-567. PubMed ID: 31970802
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer's Disease.
Hatashita S; Wakebe D; Kikuchi Y; Ichijo A
Front Aging Neurosci; 2019; 11():251. PubMed ID: 31572167
[TBL] [Abstract][Full Text] [Related]
23. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial.
Vandenberghe R; Van Laere K; Ivanoiu A; Salmon E; Bastin C; Triau E; Hasselbalch S; Law I; Andersen A; Korner A; Minthon L; Garraux G; Nelissen N; Bormans G; Buckley C; Owenius R; Thurfjell L; Farrar G; Brooks DJ
Ann Neurol; 2010 Sep; 68(3):319-29. PubMed ID: 20687209
[TBL] [Abstract][Full Text] [Related]
24. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
de Lartigue J
Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
[TBL] [Abstract][Full Text] [Related]
25. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
[TBL] [Abstract][Full Text] [Related]
26. Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease.
Nelissen N; Van Laere K; Thurfjell L; Owenius R; Vandenbulcke M; Koole M; Bormans G; Brooks DJ; Vandenberghe R
J Nucl Med; 2009 Aug; 50(8):1251-9. PubMed ID: 19617318
[TBL] [Abstract][Full Text] [Related]
27. Amyloid β accumulation assessed with ¹¹C-Pittsburgh compound B PET and postmortem neuropathology.
Hatsuta H; Takao M; Ishii K; Ishiwata K; Saito Y; Kanemaru K; Arai T; Suhara T; Shimada H; Shinotoh H; Tamaoka A; Murayama S
Curr Alzheimer Res; 2015; 12(3):278-86. PubMed ID: 25731622
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
Snellman A; Rokka J; Lopez-Picon FR; Eskola O; Wilson I; Farrar G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1784-95. PubMed ID: 22801729
[TBL] [Abstract][Full Text] [Related]
29. Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images.
Hosokawa C; Ishii K; Kimura Y; Hyodo T; Hosono M; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Murakami T
J Nucl Med; 2015 Dec; 56(12):1910-5. PubMed ID: 26359262
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
31. Temporal and anatomical distribution of
Yun T; Lee W; Kang JH; Yang MP; Kang BT
BMC Vet Res; 2020 Jan; 16(1):17. PubMed ID: 31952531
[TBL] [Abstract][Full Text] [Related]
32.
Jiménez-Bonilla JF; Quirce R; de Arcocha-Torres M; Martínez-Rodríguez I; Martínez-Amador N; Sánchez-Juan P; Pozueta A; Martín-Láez R; Banzo I; Rodríguez-Rodríguez E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):87-93. PubMed ID: 28869176
[TBL] [Abstract][Full Text] [Related]
33. Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology.
Beach TG; Thal DR; Zanette M; Smith A; Buckley C
J Alzheimers Dis; 2016 Mar; 52(3):863-73. PubMed ID: 27031469
[TBL] [Abstract][Full Text] [Related]
34. Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.
Heurling K; Leuzy A; Zimmer ER; Lubberink M; Nordberg A
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):362-373. PubMed ID: 26440450
[TBL] [Abstract][Full Text] [Related]
35. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
[TBL] [Abstract][Full Text] [Related]
36. Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale.
Rowe CC; Jones G; Doré V; Pejoska S; Margison L; Mulligan RS; Chan JG; Young K; Villemagne VL
J Nucl Med; 2016 Aug; 57(8):1233-7. PubMed ID: 26912446
[TBL] [Abstract][Full Text] [Related]
37. Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer's disease.
Kondo M; Tokuda T; Itsukage M; Kuriyama N; Matsushima S; Yamada K; Nakanishi H; Ishikawa M; Nakagawa M
Neuroradiol J; 2013 Feb; 26(1):41-6. PubMed ID: 23859166
[TBL] [Abstract][Full Text] [Related]
38. Amyloid deposits and response to shunt surgery in idiopathic normal-pressure hydrocephalus.
Hiraoka K; Narita W; Kikuchi H; Baba T; Kanno S; Iizuka O; Tashiro M; Furumoto S; Okamura N; Furukawa K; Arai H; Iwata R; Mori E; Yanai K
J Neurol Sci; 2015 Sep; 356(1-2):124-8. PubMed ID: 26095458
[TBL] [Abstract][Full Text] [Related]
39. Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
Müller EG; Edwin TH; Strand BH; Stokke C; Revheim ME; Knapskog AB
J Alzheimers Dis; 2022; 85(1):197-205. PubMed ID: 34776444
[TBL] [Abstract][Full Text] [Related]
40. [18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose.
Kalheim LF; Fladby T; Coello C; Bjørnerud A; Selnes P
J Alzheimers Dis; 2018; 62(4):1595-1607. PubMed ID: 29504529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]